1. Home
  2. ESI vs SYRE Comparison

ESI vs SYRE Comparison

Compare ESI & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Element Solutions Inc.

ESI

Element Solutions Inc.

N/A

Current Price

$39.22

Market Cap

9.2B

Sector

Industrials

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$104.60

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESI
SYRE
Founded
1922
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
8.5B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
ESI
SYRE
Price
$39.22
$104.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$35.56
$85.08
AVG Volume (30 Days)
4.2M
760.4K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
0.75%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
$2,551,200,000.00
N/A
Revenue This Year
$21.24
N/A
Revenue Next Year
$7.34
N/A
P/E Ratio
$168.74
N/A
Revenue Growth
3.84
N/A
52 Week Low
$22.86
$14.51
52 Week High
$49.25
$108.14

Technical Indicators

Market Signals
Indicator
ESI
SYRE
Relative Strength Index (RSI) 51.78 56.94
Support Level $38.39 $92.37
Resistance Level $39.19 $105.09
Average True Range (ATR) 1.18 5.39
MACD 0.39 -0.38
Stochastic Oscillator 92.24 73.40

Price Performance

Historical Comparison
ESI
SYRE

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: